McLean Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
McLean Asset Management's LLY Position: Q2 2026 in Review
McLean Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $21.5K and leaving 1,420 shares worth $1.63M. The position accounts for 0.22% of the portfolio, ranked #43.
McLean Asset Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- McLean Asset Management held 1,420 shares of Eli Lilly worth $1.63M as of Q2 2026.
- McLean Asset Management sold 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
- Eli Lilly made up 0.22% of McLean Asset Management's portfolio in Q2 2026, its #43 holding.
- McLean Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on McLean Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.